Literature DB >> 20404152

Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stage.

Miguel A Morales1, Reiko Watanabe, Mariko Dacher, Philippe Chafey, José Osorio y Fortéa, David A Scott, Stephen M Beverley, Gabi Ommen, Joachim Clos, Sonia Hem, Pascal Lenormand, Jean-Claude Rousselle, Abdelkader Namane, Gerald F Späth.   

Abstract

Leishmania is exposed to a sudden increase in environmental temperature during the infectious cycle that triggers stage differentiation and adapts the parasite phenotype to intracellular survival in the mammalian host. The absence of classical promoter-dependent mechanisms of gene regulation and constitutive expression of most of the heat-shock proteins (HSPs) in these human pathogens raise important unresolved questions as to regulation of the heat-shock response and stage-specific functions of Leishmania HSPs. Here we used a gel-based quantitative approach to assess the Leishmania donovani phosphoproteome and revealed that 38% of the proteins showed significant stage-specific differences, with a strong focus of amastigote-specific phosphoproteins on chaperone function. We identified STI1/HOP-containing chaperone complexes that interact with ribosomal client proteins in an amastigote-specific manner. Genetic analysis of STI1/HOP phosphorylation sites in conditional sti1(-/-) null mutant parasites revealed two phosphoserine residues essential for parasite viability. Phosphorylation of the major Leishmania chaperones at the pathogenic stage suggests that these proteins may be promising drug targets via inhibition of their respective protein kinases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404152      PMCID: PMC2889574          DOI: 10.1073/pnas.0914768107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Life without transcriptional control? From fly to man and back again.

Authors:  Christine E Clayton
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

2.  Isolation of a mouse cDNA encoding mSTI1, a stress-inducible protein containing the TPR motif.

Authors:  G L Blatch; M Lässle; B R Zetter; V Kundra
Journal:  Gene       Date:  1997-07-31       Impact factor: 3.688

Review 3.  Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement.

Authors:  William B Pratt; Mario D Galigniana; Jennifer M Harrell; Donald B DeFranco
Journal:  Cell Signal       Date:  2004-08       Impact factor: 4.315

Review 4.  Post-transcriptional regulation of gene expression in trypanosomes and leishmanias.

Authors:  Christine Clayton; Michal Shapira
Journal:  Mol Biochem Parasitol       Date:  2007-07-19       Impact factor: 1.759

5.  Heat shock protein 90 homeostasis controls stage differentiation in Leishmania donovani.

Authors:  M Wiesgigl; J Clos
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

6.  Methylene tetrahydrofolate dehydrogenase/cyclohydrolase and the synthesis of 10-CHO-THF are essential in Leishmania major.

Authors:  Silvane M F Murta; Tim J Vickers; David A Scott; Stephen M Beverley
Journal:  Mol Microbiol       Date:  2009-01-16       Impact factor: 3.501

Review 7.  Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans.

Authors:  Anne-Laure Bañuls; Mallorie Hide; Franck Prugnolle
Journal:  Adv Parasitol       Date:  2007       Impact factor: 3.870

8.  Molecular characterization of the heat-inducible LmSTI1 protein of Leishmania major.

Authors:  J R Webb; A Campos-Neto; Y A Skeiky; S G Reed
Journal:  Mol Biochem Parasitol       Date:  1997-11       Impact factor: 1.759

9.  Estimation of population at risk of infection and number of cases of Leishmaniasis.

Authors:  R W Ashford; P Desjeux; P Deraadt
Journal:  Parasitol Today       Date:  1992-03

10.  Reference-facilitated phosphoproteomics: fast and reliable phosphopeptide validation by microLC-ESI-Q-TOF MS/MS.

Authors:  Susumu Y Imanishi; Vitaly Kochin; Saima E Ferraris; Aurélie de Thonel; Hanna-Mari Pallari; Garry L Corthals; John E Eriksson
Journal:  Mol Cell Proteomics       Date:  2007-05-17       Impact factor: 5.911

View more
  46 in total

Review 1.  The genetics of Leishmania virulence.

Authors:  Eugenia Bifeld; Joachim Clos
Journal:  Med Microbiol Immunol       Date:  2015-06-06       Impact factor: 3.402

Review 2.  Protein quality control machinery in intracellular protozoan parasites: hopes and challenges for therapeutic targeting.

Authors:  Mohammad Anas; Varsha Kumari; Niharika Gupta; Anuradha Dube; Niti Kumar
Journal:  Cell Stress Chaperones       Date:  2019-06-21       Impact factor: 3.667

3.  Leishmania donovani P23 protects parasites against HSP90 inhibitor-mediated growth arrest.

Authors:  Antje Hombach; Gabi Ommen; Victoria Sattler; Joachim Clos
Journal:  Cell Stress Chaperones       Date:  2015-05-07       Impact factor: 3.667

4.  Comparative genomics of Tunisian Leishmania major isolates causing human cutaneous leishmaniasis with contrasting clinical severity.

Authors:  Amel Ghouila; Fatma Z Guerfali; Chiraz Atri; Aymen Bali; Hanene Attia; Rabiaa M Sghaier; Ghada Mkannez; Nicholas J Dickens; Dhafer Laouini
Journal:  Infect Genet Evol       Date:  2016-11-04       Impact factor: 3.342

Review 5.  Heat Shock Proteins as the Druggable Targets in Leishmaniasis: Promises and Perils.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

6.  Leishmania phosphatase PP5 is a regulator of HSP83 phosphorylation and essential for parasite pathogenicity.

Authors:  Brianna Norris-Mullins; Joseph S Krivda; Kathryn L Smith; Micah J Ferrell; Miguel A Morales
Journal:  Parasitol Res       Date:  2018-07-08       Impact factor: 2.289

7.  Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability.

Authors:  Wai-Lok Yau; Thierry Blisnick; Jean-François Taly; Manuela Helmer-Citterich; Cordelia Schiene-Fischer; Olivier Leclercq; Jing Li; Dirk Schmidt-Arras; Miguel A Morales; Cedric Notredame; Daniel Romo; Philippe Bastin; Gerald F Späth
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

8.  Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.

Authors:  Najma Rachidi; Jean François Taly; Emilie Durieu; Olivier Leclercq; Nathalie Aulner; Eric Prina; Pascale Pescher; Cedric Notredame; Laurent Meijer; Gerald F Späth
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

9.  A global view of Hsp90 functions.

Authors:  Gabriela Chiosis; Chad A Dickey; Jill L Johnson
Journal:  Nat Struct Mol Biol       Date:  2013-01       Impact factor: 15.369

10.  Regulation dynamics of Leishmania differentiation: deconvoluting signals and identifying phosphorylation trends.

Authors:  Polina Tsigankov; Pier Federico Gherardini; Manuela Helmer-Citterich; Gerald F Späth; Peter J Myler; Dan Zilberstein
Journal:  Mol Cell Proteomics       Date:  2014-04-16       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.